Safety Evaluation of IV Tc 99m Tilmanocept and Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASH

PHASE1

Phase

TERMINATED

Status

Enrollment

INDUSTRY

Sponsor class

Stopped No meaningful differences in the pattern of liver uptake were observed between Tc 99m tilmanocept and the comparator (Tc 99m sulfur colloid) after a review of the first six subjects.

Conditions

Nonalcoholic Steatohepatitis
NASH - Nonalcoholic Steatohepatitis

Interventions

DRUG: Tc 99M Sulfur Colloid
DRUG: Tc99m-tilmanocept

Sponsor

Navidea Biopharmaceuticals